1, 3-disubstituted azetidine derivatives for use as CCR-3 receptor antagonists in the treatment of inflammatory and allergic diseases

Details for Australian Patent Application No. 2004272275 (hide)

Owner Novartis AG

Inventors Le Grand, Darren Mark

Agent Davies Collison Cave

Pub. Number AU-B-2004272275

PCT Pub. Number WO2005/026113

Priority 0321600.9 15.09.03 GB; 0321599.3 15.09.03 GB

Filing date 14 September 2004

Wipo publication date 24 March 2005

Acceptance publication date 26 February 2009

International Classifications

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

C07D 205/04 (2006.01) Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

9 March 2006 PCT application entered the National Phase

  PCT publication WO2005/026113 Priority application(s): WO2005/026113

26 February 2009 Application Accepted

  Published as AU-B-2004272275

25 June 2009 Standard Patent Sealed

7 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004272280-Matrix metalloproteinase inhibitors

2004272272-Base-substituted benzylamine analogs for use as coagulation factor Xa inhibitors, the production and use thereof